HPV-driven oropharyngeal cancer burden in Paris and its region (ILE DE FRANCE) from 1981 TO 2021
Cancer Epidemiology · 2024-08 · 91 · 102603
DOI: 10.1016/j.canep.2024.102603 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Epidemiology, 2024-08. Verfasst von Haitham Mirghani und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology and Head and Neck surgery, Georges Pompidou European hospital, Université Paris Cité, 20 rue Leblanc, Paris, France…. Hauptthemen laut MEDLINE: Oropharyngeal Neoplasms, Papillomavirus Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: Meso Scale Diagnostics.
Abstract (Originalsprache)
BACKGROUND: France has the sixth highest incidence of oropharyngeal cancer (OPC) in Europe, but the epidemiological impact of high-risk HPV (HR-HPV) remains poorly documented. The objective of our study was to assess the proportion of OPCs caused by HR-HPV in Paris, and its suburbs, over the four past decades. This area accounts for almost one-fifth of the total population of France. METHODS: OPCs diagnosed in 1981, 1986, 1991, 1996, 2001, 2006, 2011, 2016 and 2020/2021 in two of the main referral cancer centers for HNCs in Paris and its suburbs were retrieved from the tumor biobanks. HPV status was determined by p16-staining and HPV-DNA detection. Samples were considered HPV-driven if both assays were positive. Results were compared to the French cancer registry data. RESULTS: Samples from 697 OPC patients were assessed (including 82 % of all samples diagnosed in 2001, 2006, 2011, 2016, 2021). The proportion of HPV-driven cases rose from 2.7 % to 53 % between 1981 and 2021. HPV16 was the dominant genotype during the study period. Of patients with HPV-driven OPC, 81 % were male and 42 % were smokers versus 80 % and 92 % in their HPV-negative counterparts. The age of OPC patients increased significantly, during the study period, independent of their HPV status CONCLUSION: The proportion of HPV-driven OPCs has significantly increased in Paris and its suburbs, during the last four decades. OPCs has become the 2nd predominant type of head and neck cancer, in France. This may be linked to the rise in HPV-driven cases and the decrease of tobacco and alcohol consumption in men.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otorhinolaryngology and Head and Neck surgery, Georges Pompidou European hospital, Université Paris Cité, 20 rue Leblanc, Paris, France. Electronic address: haitham.mirghani@aphp.fr.
- Department of Head and Neck oncology, Gustave Roussy Cancer Campus, 114 rue Edouard Vaillant, Villejuif, France.
- Department of Epidemiology and Statistics, Gustave Roussy Cancer Campus, 114 rue Edouard Vaillant, Villejuif, France.
- Department of Pathology, Gustave Roussy Cancer Campus, 114 rue Edouard Vaillant, Villejuif, France.
- Department of Pathology, Hôpital Européen Georges Pompidou, 20 rue Leblanc, Paris, France.
- Laboratory of Biopathology, Reims University Hospital - Maison Blanche, Reims-Champagne-Ardenne University, Reims 51092, France.
Förderung
- Meso Scale Diagnostics
Zitieren
APA
Mirghani, H., Tendron, A., Auperin, A., Casiraghi, O., Classe, M., Badoual, C., Legoupil, C., Puech, J., Veyer, D., Dalstein, V., Pere, H., & Gorphe, P. (2024). HPV-driven oropharyngeal cancer burden in Paris and its region (ILE DE FRANCE) from 1981 TO 2021. Cancer Epidemiology, 91, 102603. https://doi.org/10.1016/j.canep.2024.102603
Vancouver
Mirghani H, Tendron A, Auperin A, Casiraghi O, Classe M, Badoual C, et al. HPV-driven oropharyngeal cancer burden in Paris and its region (ILE DE FRANCE) from 1981 TO 2021. Cancer Epidemiology. 2024;91:102603. doi:10.1016/j.canep.2024.102603
BibTeX
@article{Mirghani2024,
author = {Mirghani, Haitham and Tendron, Alexandre and Auperin, Anne and Casiraghi, Odile and Classe, Marion and Badoual, Cécile and Legoupil, Clémence and Puech, Julien and Veyer, David and Dalstein, Véronique and Pere, Hélène and Gorphe, Philippe},
title = {HPV-driven oropharyngeal cancer burden in Paris and its region (ILE DE FRANCE) from 1981 TO 2021},
journal = {Cancer Epidemiology},
year = {2024},
volume = {91},
pages = {102603},
doi = {10.1016/j.canep.2024.102603}
}
EUVIMED